MetaCap

Carlsmed (CARL) vs Avita Medical (RCEL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Avita Medical (RCEL) has outperformed Carlsmed (CARL) over the past year, gaining 312.1% versus a gain of 39.5%. Avita Medical is the larger company by market cap ($495.0 million vs $477.4 million), about 1.0 times the size, while Carlsmed is growing revenue faster (+85.9% vs +11.5%). Carlsmed converts more of its revenue into profit, with a net margin of -58.7% versus -67.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CARL+39.47%RCEL+312.14%
+385%+168%-49%
Nov 21, 20251 yearNov 20, 2026
CARL+20.14%RCEL+170.71%
+199%+73%-53%
Jul 21, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CARL versus RCEL key metrics
MetricCARLRCEL
Share price$17.42$15.62
Market cap$477.38M$494.96M
1-day change+1.16%-2.31%
YTD return+41.05%+352.75%
1-year return+39.47%+312.14%
5-year return—+10.78%
EPS (TTM)$-1.13$-1.17
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$50.51M$71.61M
Revenue growth (YoY)+85.94%+11.45%
Net income (latest FY)$-29.63M$-48.59M
Gross margin75.31%82.13%
Operating margin-60.53%-59.40%
Net margin-58.67%-67.85%
52-week high$19.15$18.43
52-week low$8.50$3.22
Distance from 52-week high-9.05%-15.25%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+26.29%+32.46%
Average volume112.80K417.02K
Shares outstanding27.40M31.69M
Employees127226
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RCEL has outperformed CARL by 272.7 percentage points over the past year.
  • Carlsmed is more profitable, keeping -58.7 cents of every revenue dollar as net income versus -67.8 cents for Avita Medical.
  • Carlsmed grew revenue faster in its latest fiscal year (+85.94% vs +11.45%).

About Carlsmed

CARL stock →

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Health Care · Medical/Dental Instruments · 127 employees

About Avita Medical

RCEL stock →

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.

Health Care · Medical/Dental Instruments · 226 employees

CARL vs RCEL FAQ

Which is bigger, Carlsmed or Avita Medical?

Avita Medical (RCEL) is larger, with a market capitalization of $494.96M compared with $477.38M for Carlsmed (CARL).

Which stock has performed better over the past year, CARL or RCEL?

RCEL returned +312.14% over the past 12 months, compared with +39.47% for CARL (price return, excluding dividends). Past performance does not predict future results.

Are Carlsmed and Avita Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons